Nevertheless, mTORC1 contributes to malignant transformation induced by Akt activation because rapamycin decreases the incidence of T-cell lymphomas in murine models using constitutively active AKT [133]. This evidence concerns the gene AKT1 and T-cell non-Hodgkin lymphoma.